The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for kids ages 12 to 15 by next week, setting up shots for many before the beginning of the next school year.
The Food and Drug Administration is taking steps to ban menthol flavored cigarettes and all flavored cigars within the next year. Ultimately, the goal is to reduce disease and death from those products.
The South Carolina Department of Health and Environmental Control says they are putting an immediate pause on the distribution of the Johnson & Johnson coronavirus vaccine in the state.
The Food and Drug Administration approved several at-home COVID-19 tests. Over-the-counter products from Abbott and Quidel got emergency use authorization Wednesday. They’re for asymptomatic people involved with serial screening and those testing for antigens.
Pfizer says its COVID-19 vaccine is effective in adolescents. The pharmaceutical company says clinical trial results showed 100% efficacy in kids ages 12-15. Researchers say there were no COVID-19 cases among the more than 100,000 participants given the vaccine.
The Food and Drug Administration has authorized another at-home COVID-19 test for emergency use. The federal agency green lit the Quidel QuickVue at-home COVID-19 test.
American consumer spending jumped in the month of January. Spending increased by 2.4% last month, the biggest jump since June, thanks to stimulus checks. Incomes also rose 10% in January, which is the biggest increase since April of last year.
The United States could have authorization to begin administering a third COVID-19 vaccine in a few days. Food and Drug Administration advisors are meeting Friday to review the Johnson & Johnson vaccine.
Federal officials are sending millions of masks to areas hit hard by the coronavirus. Meanwhile, the effort to vaccinate ramps up, and a third vaccine could soon be making its way across the country, if it gets authorized for emergency use by the Food and Drug Administration.
The Food and Drug Administration is set to review a third vaccine, this one from Johnson & Johnson. Fewer than 28 million Americans have received a COVID-19 vaccine so far, and this new shot could speed up the process.
